Research Report for the year 2016

Scientific publications

Journal Articles:
  • Ahrens TD, Timme S, Ostendorp J, Bogatyreva L, Hoeppner J, Hopt UT, Hauschke D, Werner M, Lassmann S: Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity. Lab Invest, 2016; 96: 307-316. : http://dx.doi.org/10.1038/labinvest.2015.148
  • Aumann K, Niermann K, Asberger J, Wellner U, Bronsert P, Erbes T, Hauschke D, Stickeler E, Gitsch G, Kayser G, Werner M: Structured reporting ensures complete content and quick detection of essential data in pathology reports of oncological breast resection specimens. Breast Cancer Res Tr, 2016; 156: 495-500. : http://dx.doi.org/10.1007/s10549-016-3769-0
  • Goebel U, Gebele N, Ebner W, Dettenkofer M, Bürkle H, Hauschke D, Schulz-Stübner S: Bacterial Contamination of the Anesthesia Workplace and Efficiency of Routine Cleaning Procedures: A Prospective Cohort Study. Anesth Analg, 2016; 122: 1444-1447. : http://dx.doi.org/10.1213/ANE.0000000000001220
  • Hochholzer w, Amann M, Tito A, Younas I, Löffelhardt N, Riede F, Potocnik C, Stratz C, Hauschke D, Trenk D, Neumann F-J, Valina CM: Randomized Comparison of Different Thienopyridine Loading Strategies in Patients Undergoing Elective Coronary Intervention: The ExcelsiorLOAD Trial. Jacc-cardiovasc Inte, 2016; 9: 219-227. : http://dx.doi.org/10.1016/j.jcin.2015.10.036
  • Lutz L, Fitzner IC, Ahrens T, Geißler AL, Makowiec F, Hopt UT, Bogatyreva L, Hauschke D, Werner M, Lassmann S: Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro. Am J Cancer Res, 2016; 6: 664-676.
  • Machado V, Gilsbach R, Das R, Schober A, Bogatyreva L, Hauschke D, Krieglstein K, Unsicker K, Spittau B: Gdf-15 deficiency does not alter vulnerability of nigrostriatal dopaminergic system in MPTP-intoxicated mice. Cell Tissue Res, 2016; 365: 209-223. : http://dx.doi.org/10.1007/s00441-016-2406-x
  • Michalska M, Schultze-Seemann S, Bogatyreva L, Hauschke D, Wetterauer U, Wolf: In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer. Oncotarget, 2016; 7 (16): 22531-22542. : http://dx.doi.org/10.18632/oncotarget.8001
Short Communications: